SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-12-052548
Filing Date
2012-02-10
Accepted
2012-02-10 16:16:35
Documents
1
Group Members
JACOB GOTTLIEBJG ASSET, LLCLUMX VISIUM CREDIT FUND LTDVISIUM BALANCED MASTER FUND, LTDVISIUM CREDIT MASTER FUND, LTD

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G AMENDMENT NO. 1 d299165dsc13ga.htm SC 13G/A 170128
  Complete submission text file 0001193125-12-052548.txt   171864
Mailing Address ONE CORPORATE WOODS DRIVE BRIDGETON MO 63044
Business Address ONE CORPORATE WOODS DRIVE BRIDGETON MO 63044 3146456600
KV PHARMACEUTICAL CO /DE/ (Subject) CIK: 0000057055 (see all company filings)

IRS No.: 430618919 | State of Incorp.: DE | Fiscal Year End: 0331
Type: SC 13G/A | Act: 34 | File No.: 005-12338 | Film No.: 12593110
SIC: 2834 Pharmaceutical Preparations

Mailing Address 950 THIRD AVENUE, 29TH FLOOR NEW YORK NY 10022
Business Address 950 THIRD AVENUE, 29TH FLOOR NEW YORK NY 10022 646 840 5800
Visium Asset Management, LP (Filed by) CIK: 0001377452 (see all company filings)

IRS No.: 203313013 | Fiscal Year End: 1231
Type: SC 13G/A